// App-Quantinova.ai

23 : Effects of Dabigatran and Rivaroxaban On Routine and Specialized Coagulation Assays: A Study Using Actual Patient Plasma Samples

Researchers

Presenter

  • Leslie Zypchen

Principal Investigators

  • Cedric J. Carter

  • Annie Tran

  • Pamela Colley

  • Kenneth Gin

  • Philip Teal

  • Bassam A. Masri

  • Agnes Y.Y. Lee

Medical Centers

  • Division of Hematology, University of British Columbia, Vancouver, BC, Canada

  • Division of Hematology, University of British Columbia, Vancouver, BC, Canada

  • Department of Pathology and Laboratory Medicine, Vancouver General Hospital, University of British Columbia, Vancouver, BC, Canada

  • The University of British Columbia, Vancouver, BC, Canada

  • Division of Hematology, University of British Columbia, Vancouver, BC, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Arrhythmia

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • rivaroxaban

  • FVIII

  • Fibrinogen (IV)

  • Pradax

  • Protein C

  • Evithrom

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved